Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.

This landmark trial is the largest-to-date and was only made possible because of the seminal work of Australian scientists from the ...

Ahead of Little Big Town's Nashville Christmas residency, the chart-topping country artist opens up about her mother's ...

Gibson's most famous moment came 37 years ago this month. Now he's leading another team towards a very different goal.

Trials have shown the novel treatment appears to "reset" faulty wiring, helping patients move properly again - and early ...

A singing group is helping islanders with Parkinsons or dementia be more confident. The weekly singing sessions also help ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Friends of a man living with Parkinson's disease have reunited to record a song he wrote more than 50 years ago. Dave Wells, ...

Parkinson’s — which can cause tremors, slow movement and stiffness — is believed to affect 1 in every 336 Americans.

Restless legs syndrome, a condition affecting millions of Americans, may be tied to increased Parkinson’s risk, according to ...

HONOLULU, Oct. 5, 2025 /PRNewswire/ -- Preliminary findings for dopaminergic cell transplantation have reported positive trends towards safety and efficacy for people with Parkinson's disease (PD), ...